Documentaires
le (18m28s)
Résultats de recherche
Trier par :
Nombre de programmes trouvés : 6
Conférences
le (14m26s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Will we be able to answer the question of HDL as a therapeutic target after the CETP inhibitor trials? (Eric STROES)
... patients with specific biomarkers profiles? e.g. low HDL, high inflammatory burden (elevated CRP), high Lp-PLA2 activity etc.?➢ A fairly large number of lipid-associated new targets or targets reflecting other pathways of the complex atherosclerotic process... Voir la vidéo
Conférences
le (58m17s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Will we be able to answer the question of HDL as a therapeutic target after the CETP inhibitor trials? (Robert ROSENSON)
... patients with specific biomarkers profiles? e.g. low HDL, high inflammatory burden (elevated CRP), high Lp-PLA2 activity etc.?➢ A fairly large number of lipid-associated new targets or targets reflecting other pathways of the complex atherosclerotic process... Voir la vidéo
Conférences
le (1h6m55s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Identifying new targets: The value of omics and mendelian randomization studies (Daniel SWERDLOW)
... patients with specific biomarkers profiles? e.g. low HDL, high inflammatory burden (elevated CRP), high Lp-PLA2 activity etc.?➢ A fairly large number of lipid-associated new targets or targets reflecting other pathways of the complex atherosclerotic process... Voir la vidéo
Conférences
le (16m50s)
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Identifying new targets: Monoclonal Antibody Inhibitor of PCSK9 (Wolfgang KOENIG)
... patients with specific biomarkers profiles? e.g. low HDL, high inflammatory burden (elevated CRP), high Lp-PLA2 activity etc.?➢ A fairly large number of lipid-associated new targets or targets reflecting other pathways of the complex atherosclerotic process... Voir la vidéo
Conférences
le (1h43m30s)
